![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Liver Diseases |
Free Subscription
4 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Diseases is free of charge.
Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological
suppression: a randomised, open-label trial.
Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
PubMed
Abstract available
Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in
critically ill patients with cirrhosis: A double-blind, randomized controlled
(ARiE) trial.
Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
PubMed
Abstract available
Predictors of Respiratory Failure Development in A Multi-Center Cohort of
Inpatients with Cirrhosis.
Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
PubMed
Abstract available
Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care
Planning in Patients with Decompensated Cirrhosis.
Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
PubMed
Abstract available
Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase
Inhibition in Alcohol-Associated Liver Disease.
Am J Pathol. 2023 Nov 2:S0002-9440(23)00410-8. doi: 10.1016/j.ajpath.2023.
PubMed
Abstract available
Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte
differentiation in zebrafish.
Biochem Biophys Res Commun. 2023;686:149182.
PubMed
Abstract available
The microRNA-195-5p/hnRNP A1 axis contributes to the progression of
hepatocellular carcinoma by regulating the migration of cancer cells.
Biochem Biophys Res Commun. 2023;686:149183.
PubMed
Abstract available
PTEN/AKT and Wnt/beta-catenin signaling pathways regulate the proliferation of Lgr5+
cells in liver cancer.
Biochem Biophys Res Commun. 2023;683:149117.
PubMed
Abstract available
Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat
diet-induced nonalcoholic fatty liver disease in mice.
Biochem Biophys Res Commun. 2023;684:149131.
PubMed
Abstract available
Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of
hepatocellular carcinoma: a prospective study.
BMC Cancer. 2023;23:1081.
PubMed
Abstract available
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced
hepatocarcinogenesis.
BMC Cancer. 2023;23:1086.
PubMed
Abstract available
A deep-learning approach for segmentation of liver tumors in magnetic resonance
imaging using UNet+.
BMC Cancer. 2023;23:1060.
PubMed
Abstract available
Prediction of survival and analysis of prognostic factors for hepatocellular
carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand.
BMC Cancer. 2023;23:1063.
PubMed
Abstract available
Triglyceride glucose-waist circumference: the optimum index to screen
nonalcoholic fatty liver disease in non-obese adults.
BMC Gastroenterol. 2023;23:376.
PubMed
Abstract available
Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a
nationwide multicentre study.
Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.
PubMed
Erratum to "Association between posttreatment alpha-fetoprotein reduction and
outcomes in real-world US patients with advanced hepatocellular carcinoma".
Cancer. 2023 Nov 4. doi: 10.1002/cncr.35102.
PubMed
Clin Res Hepatol Gastroenterol
Featuring molecular regulation of bile acid homeostasis in pediatric short bowel
syndrome.
Clin Res Hepatol Gastroenterol. 2023;47:102220.
PubMed
Abstract available
Difficulties in assessing portal hypertension in case of HVB-HVD co infection.
Clin Res Hepatol Gastroenterol. 2023;47:102213.
PubMed
Determinants of early surgical complications after pediatric liver
transplantation: A single center/single surgeon experience over 20 years.
Clin Res Hepatol Gastroenterol. 2023;47:102222.
PubMed
Abstract available
Non-invasive Tests of Fibrosis: Does One Size Fit All?
Dig Dis Sci. 2023;68:4285-4286.
PubMed
Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic
Fatty Liver Disease: A Multicentric Asian Study.
Dig Dis Sci. 2023;68:4485-4498.
PubMed
Abstract available
Alternatives to animal testing to assess NASH drugs and hepatotoxicity.
Hepatology. 2023 Nov 6. doi: 10.1097/HEP.0000000000000669.
PubMed
Abstract available
Cystic fibrosis screening, evaluation and management of hepatobiliary disease
consensus recommendations.
Hepatology. 2023 Oct 26. doi: 10.1097/HEP.0000000000000646.
PubMed
Abstract available
Navigating the 'Specific Etiology' steatohepatitis category: Evaluation &
management of non-alcohol/non-metabolic dysfunction-associated steatohepatitis.
Hepatology. 2023 Nov 7. doi: 10.1097/HEP.0000000000000674.
PubMed
MicroRNA-206-3p suppresses hepatic lipogenesis and cholesterol synthesis while
driving cholesterol efflux.
Hepatology. 2023 Nov 9. doi: 10.1097/HEP.0000000000000672.
PubMed
Abstract available
AASLD Practice guidance on Acute-on-chronic liver failure and the management of
critically Ill patients with cirrhosis.
Hepatology. 2023 Nov 9. doi: 10.1097/HEP.0000000000000671.
PubMed
Non-cirrhotic intrahepatic portal hypertension: Is the gun loaded?
Indian J Gastroenterol. 2023 Nov 9. doi: 10.1007/s12664-023-01466.
PubMed
Evaluation of liver and splenic stiffness by acoustic radiation force impulse for
assessment of esophageal varices.
Indian J Gastroenterol. 2023 Nov 6. doi: 10.1007/s12664-023-01456.
PubMed
Abstract available
Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor
for Young-Onset Digestive Tract Cancers.
J Clin Oncol. 2023;41:5070.
PubMed
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated
with hepatitis B virus.
J Gastroenterol. 2023 Nov 5. doi: 10.1007/s00535-023-02053.
PubMed
Abstract available
Patients with Hepatocellular carcinoma and portal vein tumour thrombosis after
successful downstaging may be candidates for liver transplantation:A
meta-analysis.
J Hepatol. 2023 Nov 6:S0168-8278(23)05231-5. doi: 10.1016/j.jhep.2023.
PubMed
Hepatic Vitamin A Concentrations and Association with Infectious Causes of Child
Death.
J Pediatr. 2023 Nov 4:113816. doi: 10.1016/j.jpeds.2023.113816.
PubMed
Abstract available
Outcomes of Primary Tumor Excision do not Differ from Non-Resection Methods in
Pediatric Mesenchymal Hamartoma of the Liver: A Rapid Systematic Review.
J Pediatr Surg. 2023;58:2356-2361.
PubMed
Abstract available
Predictive Factors of Liver Hydatid Cyst Recurrence in Children.
J Pediatr Surg. 2023;58:2362-2367.
PubMed
Abstract available
AATD as a genetic risk factor for aneurysmal disease - Authors' reply.
Lancet. 2023;402:1626.
PubMed
AATD as a genetic risk factor for aneurysmal disease.
Lancet. 2023;402:1625-1626.
PubMed
GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and
histone lactylation via Hippo pathway.
Oncogene. 2023 Sep 25. doi: 10.1038/s41388-023-02841.
PubMed
Abstract available
MYC in liver cancer: mechanisms and targeted therapy opportunities.
Oncogene. 2023;42:3303-3318.
PubMed
Abstract available
Non-linear association between aspartate aminotransferase to alanine
aminotransferase ratio and mortality in critically ill older patients: A
retrospective cohort study.
PLoS One. 2023;18:e0293749.
PubMed
Abstract available
Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver
transplant renal outcomes.
PLoS One. 2023;18:e0293844.
PubMed
Abstract available
Noninferiority in Overall Survival with Thermal Ablation for Treating Small
Colorectal Liver Metastases.
Radiol Imaging Cancer. 2023;5:e239020.
PubMed
Development of a Model including MRI Features for Predicting Advanced-stage
Recurrence of Hepatocellular Carcinoma after Liver Resection.
Radiology. 2023;309:e230527.
PubMed
Abstract available
Using Machine Learning to Predict Response to Image-guided Therapies for
Hepatocellular Carcinoma.
Radiology. 2023;309:e222891.
PubMed
Abstract available
Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular
Carcinoma.
Radiology. 2023;309:e232480.
PubMed
The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver
Disease.
Radiology. 2023;309:e223146.
PubMed
Abstract available
Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular
Carcinoma.
Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
PubMed
Abstract available
Thank you for your interest in scientific medicine.